TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07034794: A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Examine Lysoveta on Cognitive Function in Healthy Adults With Self-perceived Memory Problems

Sponsor: Aker BioMarine Human Ingredients AS · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 138 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07034794 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07034794 Rescue Dossier →